Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3937704
[patent_doc_number] => 05872007
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer'
[patent_app_type] => 1
[patent_app_number] => 8/502374
[patent_app_country] => US
[patent_app_date] => 1995-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 9539
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/872/05872007.pdf
[firstpage_image] =>[orig_patent_app_number] => 502374
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/502374 | CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer | Jul 13, 1995 | Issued |
Array
(
[id] => 3648591
[patent_doc_number] => 05639736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => 'Human VEGF-specific oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/502185
[patent_app_country] => US
[patent_app_date] => 1995-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 11177
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639736.pdf
[firstpage_image] =>[orig_patent_app_number] => 502185
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/502185 | Human VEGF-specific oligonucleotides | Jul 12, 1995 | Issued |
Array
(
[id] => 3695650
[patent_doc_number] => 05661135
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Human VEGF-specific oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/501779
[patent_app_country] => US
[patent_app_date] => 1995-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 11172
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661135.pdf
[firstpage_image] =>[orig_patent_app_number] => 501779
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/501779 | Human VEGF-specific oligonucleotides | Jul 12, 1995 | Issued |
Array
(
[id] => 3813533
[patent_doc_number] => 05710136
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => 'Inhibition of neovascularization using VEGF-specific oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/501713
[patent_app_country] => US
[patent_app_date] => 1995-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 11168
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/710/05710136.pdf
[firstpage_image] =>[orig_patent_app_number] => 501713
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/501713 | Inhibition of neovascularization using VEGF-specific oligonucleotides | Jul 11, 1995 | Issued |
Array
(
[id] => 3791207
[patent_doc_number] => 05726050
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Z-DNA binding protein and applications'
[patent_app_type] => 1
[patent_app_number] => 8/492599
[patent_app_country] => US
[patent_app_date] => 1995-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7870
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726050.pdf
[firstpage_image] =>[orig_patent_app_number] => 492599
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/492599 | Z-DNA binding protein and applications | Jun 19, 1995 | Issued |
Array
(
[id] => 3625051
[patent_doc_number] => 05689050
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Production of gamma linolenic acid by a .DELTA.6-desaturase'
[patent_app_type] => 1
[patent_app_number] => 8/473508
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 6400
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/689/05689050.pdf
[firstpage_image] =>[orig_patent_app_number] => 473508
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473508 | Production of gamma linolenic acid by a .DELTA.6-desaturase | Jun 6, 1995 | Issued |
Array
(
[id] => 4007707
[patent_doc_number] => 05859309
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Vector for integration site independent gene expression in mammalian host cells'
[patent_app_type] => 1
[patent_app_number] => 8/481035
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 9060
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859309.pdf
[firstpage_image] =>[orig_patent_app_number] => 481035
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481035 | Vector for integration site independent gene expression in mammalian host cells | Jun 6, 1995 | Issued |
Array
(
[id] => 3774637
[patent_doc_number] => 05849997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Vector for integration site independent gene expression in mammalian host cells'
[patent_app_type] => 1
[patent_app_number] => 8/478501
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 37
[patent_no_of_words] => 10958
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849997.pdf
[firstpage_image] =>[orig_patent_app_number] => 478501
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478501 | Vector for integration site independent gene expression in mammalian host cells | Jun 6, 1995 | Issued |
Array
(
[id] => 3814675
[patent_doc_number] => 05770449
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/483999
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 9028
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770449.pdf
[firstpage_image] =>[orig_patent_app_number] => 483999
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483999 | Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression | Jun 6, 1995 | Issued |
Array
(
[id] => 3729039
[patent_doc_number] => 05635355
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-03
[patent_title] => 'Methods of obtaining a DNA sequence for integration site independent gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/478948
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12177
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/635/05635355.pdf
[firstpage_image] =>[orig_patent_app_number] => 478948
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478948 | Methods of obtaining a DNA sequence for integration site independent gene expression | Jun 6, 1995 | Issued |
Array
(
[id] => 3769496
[patent_doc_number] => 05756353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Expression of cloned genes in the lung by aerosol-and liposome-based delivery'
[patent_app_type] => 1
[patent_app_number] => 8/487793
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8359
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756353.pdf
[firstpage_image] =>[orig_patent_app_number] => 487793
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487793 | Expression of cloned genes in the lung by aerosol-and liposome-based delivery | Jun 6, 1995 | Issued |
Array
(
[id] => 3813907
[patent_doc_number] => 05770398
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Vector for integration site independent gene expression in mammalian host cells'
[patent_app_type] => 1
[patent_app_number] => 8/483998
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 37
[patent_no_of_words] => 12219
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770398.pdf
[firstpage_image] =>[orig_patent_app_number] => 483998
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483998 | Vector for integration site independent gene expression in mammalian host cells | Jun 6, 1995 | Issued |
Array
(
[id] => 3767743
[patent_doc_number] => 05849548
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Cell ablation using trans-splicing ribozymes'
[patent_app_type] => 1
[patent_app_number] => 8/488031
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 16375
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849548.pdf
[firstpage_image] =>[orig_patent_app_number] => 488031
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488031 | Cell ablation using trans-splicing ribozymes | Jun 6, 1995 | Issued |
Array
(
[id] => 3839769
[patent_doc_number] => 05744456
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Methods for obtaining production of a gene product in a host cell in vivo or in vitro using a DNA molecule for integration site independent gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/481034
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 10967
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744456.pdf
[firstpage_image] =>[orig_patent_app_number] => 481034
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481034 | Methods for obtaining production of a gene product in a host cell in vivo or in vitro using a DNA molecule for integration site independent gene expression | Jun 6, 1995 | Issued |
Array
(
[id] => 3686618
[patent_doc_number] => 05663153
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Immune stimulation by phosphorothioate oligonucleotide analogs'
[patent_app_type] => 1
[patent_app_number] => 8/467930
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8036
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663153.pdf
[firstpage_image] =>[orig_patent_app_number] => 467930
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467930 | Immune stimulation by phosphorothioate oligonucleotide analogs | Jun 5, 1995 | Issued |
Array
(
[id] => 3686553
[patent_doc_number] => 05643788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/479173
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 8906
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643788.pdf
[firstpage_image] =>[orig_patent_app_number] => 479173
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479173 | Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides | Jun 5, 1995 | Issued |
Array
(
[id] => 3693476
[patent_doc_number] => 05650307
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Production of heterologous proteins in plants and plant cells'
[patent_app_type] => 1
[patent_app_number] => 8/469856
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8079
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650307.pdf
[firstpage_image] =>[orig_patent_app_number] => 469856
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469856 | Production of heterologous proteins in plants and plant cells | Jun 5, 1995 | Issued |
08/464417 | ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3698163
[patent_doc_number] => 05677289
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Method of cleaving specific strands of RNA and medical treatments thereby'
[patent_app_type] => 1
[patent_app_number] => 8/458050
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24518
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677289.pdf
[firstpage_image] =>[orig_patent_app_number] => 458050
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458050 | Method of cleaving specific strands of RNA and medical treatments thereby | May 31, 1995 | Issued |
08/453085 | COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS C VIRUS-ASSOCIATED DISEASES | May 29, 1995 | Abandoned |